| PACKAGING TYPE: | Blister |
| COMPOSITION: | Each Uncoated Bilayered Tablet Contains : Cilnidipine Ip 10mg, Metoprolol Succinate Ip Eq To Metoprolol Tatrate (in Extended Release Form ) 50mg |
| FORMULATION: | Tablets |
| Description: | CILOPINE M-10/50 Tablet is a combination medication containing Cilnidipine 10 mg and Metoprolol Succinate Extended Release 50 mg. It is used for the effective management of hypertension (high blood pressure). Cilnidipine, a calcium channel blocker, relaxes blood vessels and improves blood flow, while Metoprolol, a beta-blocker, reduces heart rate and cardiac workload. This dual-action combination helps achieve better blood pressure control and reduces the risk of cardiovascular complications. |
| Side Effects: | Some individuals may experience mild side effects such as: Dizziness Fatigue Slow heart rate (bradycardia) Headache Swelling of ankles If severe hypotension, breathing difficulty, or irregular heartbeat occurs, seek immediate medical attention. |
| How to Use: | Take the tablet as prescribed by a healthcare professional. Swallow the tablet whole with a glass of water; do not crush or chew (due to ER formulation). It can be taken with or without food. Take it at the same time each day for consistent results. Follow the prescribed dosage and duration strictly. |
| Precaution: | Use cautiously in patients with heart block, asthma, or liver disease. Monitor blood pressure and heart rate regularly. Do not stop the medication abruptly as it may worsen heart conditions. Pregnant or breastfeeding women should consult a healthcare professional before use. Avoid alcohol as it may enhance blood pressure-lowering effects. |
| Product Benefits: | Provides effective dual-action blood pressure control. Helps reduce the risk of heart attack and stroke. Improves heart function and reduces cardiac workload. Enhances vascular relaxation and circulation. Suitable for patients requiring combination th |
Frequently Asked Questions
It is used to treat high blood pressure and reduce cardiovascular risks.
No, it should not be stopped abruptly as it may lead to adverse heart effects.
The ER formulation ensures gradual and sustained control of heart rate and blood pressure.










